Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Pilot Study to Assess Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris
This study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adults with lichen planopilaris (LPP) or c…
Central Centrifugal Cicatricial AlopeciaLichen Planopilaris
Icahn School of Medicine at Mount SinaiNCT07487948
Phase 2
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Lichen Planopilaris
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris
Lichen Planopilaris
Priovant Therapeutics, Inc.NCT07532603